Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults

Next Previous
Trial Profile

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults

Status: Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 21 Nov 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clofarabine (Primary) ; Antineoplastics
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EORTC 06083; HOVON 100 ALL

    • Most Recent Events

    • 17 Nov 2023 This trial has been discontinued in Belgium according to European Clinical Trials Database record.
    • 08 Nov 2023 This trial has been completed in the Netherlands (Global end date: 04 Oct 2023).
    • 13 Dec 2022 Results (n=334) assessing the effect of Clofarabine in Adult Acute Lymphoblastic Leukemia presented at the 64th American Society of Hematology Annual Meeting and Exposition
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top